Yang Lang, Jin Hua, Xie Xiao-Li, Cao Yang-Tian, Liu Zhen-Hua, Li Na, Jin Peng, He Yu-Qi, Sheng Jian-Qiu
Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, No. 5 Nanmencang, Dongcheng District, Beijing, 100700, China.
Department of Pathology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.
BMC Gastroenterol. 2021 Mar 9;21(1):114. doi: 10.1186/s12876-021-01694-9.
Endoscopic resection has been used for high-grade intraepithelial neoplasia (HGIN) and superficial esophageal squamous cell carcinoma (ESCC) with limited risk of lymph node metastasis. However, some of these lesions cannot be accurately diagnosed based on forceps biopsy prior to treatment. In this study we aimed to investigate how to solve this histological discrepancy and avoid over- and under-treatment.
The medical records of patients with superficial esophageal squamous cell neoplasia who underwent endoscopic resection at our hospital from January 2012 to December 2019 were reviewed retrospectively. The histological discrepancy between the biopsy and resected specimens was calculated and its association with clinicopathological parameters was analyzed.
A total of 137 lesions from 129 patients were included. The discrepancy rate between forceps biopsy and resected specimens was 45.3% (62/137). Histological discrepancy was associated with the histological category of the biopsy (p < 0.001). In addition, 17 of the 30 (56.7%) biopsies that was diagnosed as indefinite/negative for neoplasia or low-grade intraepithelial neoplasia were upgraded to HGIN or ESCC after resection. The upgrade was due to lesion size ≥ 10 mm (p = 0.002) and type B intrapapillary capillary loops (p < 0.001). Moreover, 34 of the 83 biopsies that were diagnosed with HGIN were upgraded to ESCC after resection, which was related to lesion size (p = 0.001), location (p = 0.018), and pink color sign (p = 0.002).
Histological discrepancy between forceps biopsy and resected specimens is common in clinical practice. Recognizing the risk factors for each histological category of biopsy may reduce these discrepancies and improve clinical management.
内镜切除术已用于治疗高级别上皮内瘤变(HGIN)和浅表性食管鳞状细胞癌(ESCC),其淋巴结转移风险有限。然而,其中一些病变在治疗前通过钳取活检无法准确诊断。在本研究中,我们旨在探讨如何解决这种组织学差异并避免过度治疗和治疗不足。
回顾性分析2012年1月至2019年12月在我院接受内镜切除术的浅表性食管鳞状细胞瘤变患者的病历。计算活检标本与切除标本之间的组织学差异,并分析其与临床病理参数的相关性。
共纳入129例患者的137个病变。钳取活检与切除标本之间的差异率为45.3%(62/137)。组织学差异与活检的组织学类别相关(p<0.001)。此外,30例活检诊断为肿瘤不确定/阴性或低级别上皮内瘤变的病例中,有17例(56.7%)在切除后升级为HGIN或ESCC。升级原因是病变大小≥10 mm(p=0.002)和B型乳头内毛细血管袢(p<0.001)。此外,83例诊断为HGIN的活检中有34例在切除后升级为ESCC,这与病变大小(p=0.001)、位置(p=0.018)和粉红色征(p=0.002)有关。
钳取活检与切除标本之间的组织学差异在临床实践中很常见。识别每种活检组织学类别的危险因素可能会减少这些差异并改善临床管理。